Patents by Inventor Stephanie Yung

Stephanie Yung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating inflammatory disorders using 2,4-pyrimidinediamine compounds
    Patent number: 8575165
    Abstract: Methods for treating an inflammatory disorder and for inhibiting the production of IL-23 using 2,4-pyrimidinediamine compounds represented by formula (I):
    Type: Grant
    Filed: January 13, 2010
    Date of Patent: November 5, 2013
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Tarikere Gururaja, Donald G. Payan, Kin Tso, Taisei Kinoshita, Rongxian Ding, Rajinder Singh, Stephanie Yung, Hui Li, Esteban Masuda
  • 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders
    Patent number: 8334297
    Abstract: 2,4-Pyrimidinediamine compounds represented by formula (I), methods for preparing the same and methods for treating an inflammatory disorder and for inhibiting the production of IL-23 and/or stimulating the production of IL-10 using the same:
    Type: Grant
    Filed: January 13, 2010
    Date of Patent: December 18, 2012
    Assignee: Rigel Pharmaceuticals Inc.
    Inventors: Hui Li, Esteban Masuda, Stephanie Yung, Taisei Kinoshita, Rongxian Ding, Rajinder Singh, Tarikere Gururaja, Donald G. Payan, Kin Tso
  • METHODS FOR TREATING INFLAMMATORY DISORDERS USING 2,4-PYRIMIDINEDIAMINE COMPOUNDS
    Publication number: 20100179165
    Abstract: Methods for treating an inflammatory disorder and for inhibiting the production of IL-23 using 2,4-pyrimidinediamine compounds represented by formula (I):
    Type: Application
    Filed: January 13, 2010
    Publication date: July 15, 2010
    Inventors: Tarikere Gururaja, Donald G. Payan, Kin Tso, Taisei Kinoshita, Rongxian Ding, Rajinder Singh, Stephanie Yung, Hui Li, Esteban Masuda
  • 2,4-PYRIMIDINEDIAMINE COMPOUNDS FOR TREATMENT OF INFLAMMATORY DISORDERS
    Publication number: 20100179164
    Abstract: 2,4-Pyrimidinediamine compounds represented by formula (I), methods for preparing the same and methods for treating an inflammatory disorder and for inhibiting the production of IL-23 and/or stimulating the production of IL-10 using the same:
    Type: Application
    Filed: January 13, 2010
    Publication date: July 15, 2010
    Inventors: Hui Li, Esteban Masuda, Stephanie Yung, Taisei Kinoshita, Rongxian Ding, Rajinder Singh, Tarikere Gururaja, Donald G. Payan, Kin Tso
  • Modified IL-4 mutein receptor antagonists
    Publication number: 20050059590
    Abstract: This invention relates to modified IL-4 mutein receptor antagonists comprising an IL-4 mutein receptor antagonist coupled to polyethylene glycol. Related formulations and dosages and methods of administration thereof for therapeutic purposes are also provided. These modified IL-4 mutein receptor antagonists, compositions and methods provide a treatment option for those individuals afflicted with a respiratory disorder such as asthma by inhibiting IL-4 and IL-13-mediated airway hyperresponsiveness and eosinophilia. More particularly, these antagonists have an increased duration of effect versus unmodified IL-4RA by virtue of a greater plasma half-life.
    Type: Application
    Filed: April 8, 2004
    Publication date: March 17, 2005
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: Clark Pan, Steve Roczniak, Jeffrey Greve, Stephanie Yung, Malinda Longphre, Teresa Wong, Adrian Tomkinson